These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37489053)

  • 1. Activity Relationship of Poly(ethylenimine)-Based Liposomes as Group A
    Jin S; Zhang J; Nahar UJ; Huang W; Alharbi NA; Shalash AO; Koirala P; Yang J; Kiong JJE; Khalil ZG; Capon RJ; Stephenson RJ; Skwarczynski M; Toth I; Hussein WM
    ACS Infect Dis; 2023 Aug; 9(8):1570-1581. PubMed ID: 37489053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyethylenimine: An Intranasal Adjuvant for Liposomal Peptide-Based Subunit Vaccine against Group A
    Dai CC; Yang J; Hussein WM; Zhao L; Wang X; Khalil ZG; Capon RJ; Toth I; Stephenson RJ
    ACS Infect Dis; 2020 Sep; 6(9):2502-2512. PubMed ID: 32786276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Polyelectrolyte Complexes for the Delivery of Peptide-Based Subunit Vaccines against Group A
    Zhao L; Jin W; Cruz JG; Marasini N; Khalil ZG; Capon RJ; Hussein WM; Skwarczynski M; Toth I
    Nanomaterials (Basel); 2020 Apr; 10(5):. PubMed ID: 32357402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyethylenimine quantity and molecular weight influence its adjuvanting properties in liposomal peptide vaccines.
    Dai CC; Huang W; Yang J; Hussein WM; Wang J; Khalil ZG; Capon RJ; Toth I; Stephenson RJ
    Bioorg Med Chem Lett; 2021 May; 40():127920. PubMed ID: 33705898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.
    Olive C; Sun HK; Ho MF; Dyer J; Horváth A; Toth I; Good MF
    J Infect Dis; 2006 Aug; 194(3):316-24. PubMed ID: 16826479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembled monovalent lipidated mannose ligand as a standalone nanoadjuvant.
    Nahar UJ; Wang J; Shalash AO; Lu L; Islam MT; Alharbi N; Koirala P; Khalil ZG; Capon RJ; Hussein WM; Toth I; Skwarczynski M
    Vaccine; 2024 Oct; 42(23):126060. PubMed ID: 38897890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens.
    Olive C; Batzloff M; Horváth A; Clair T; Yarwood P; Toth I; Good MF
    Infect Immun; 2003 May; 71(5):2373-83. PubMed ID: 12704107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Multilayer Nanoparticles for the Delivery of Peptide-Based Subunit Vaccine against Group A
    Kiong J; Nahar UJ; Jin S; Shalash AO; Zhang J; Koirala P; Khalil ZG; Capon RJ; Skwarczynski M; Toth I; Hussein WM
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dual-adjuvanting strategy for peptide-based subunit vaccines against group A Streptococcus: Lipidation and polyelectrolyte complexes.
    Zhao L; Yang J; Nahar UJ; Khalil ZG; Capon RJ; Hussein WM; Skwarczynski M; Toth I
    Bioorg Med Chem; 2020 Dec; 28(24):115823. PubMed ID: 33120079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Activity Analysis of Cyclic Multicomponent Lipopeptide Self-Adjuvanting Vaccine Candidates Presenting Group A
    Madge HYR; Sharma H; Hussein WM; Khalil ZG; Capon RJ; Toth I; Stephenson RJ
    J Med Chem; 2020 May; 63(10):5387-5397. PubMed ID: 32347723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyglutamic acid-trimethyl chitosan-based intranasal peptide nano-vaccine induces potent immune responses against group A streptococcus.
    Nevagi RJ; Khalil ZG; Hussein WM; Powell J; Batzloff MR; Capon RJ; Good MF; Skwarczynski M; Toth I
    Acta Biomater; 2018 Oct; 80():278-287. PubMed ID: 30266637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship of lipid, cyclic peptide and antigen rearrangement of physically mixed vaccines.
    Huang W; Madge HYR; Zhang J; Gilmartin L; Hussein WM; Khalil ZG; Koirala P; Capon RJ; Toth I; Stephenson RJ
    Int J Pharm; 2022 Apr; 617():121614. PubMed ID: 35245637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced protection against Streptococcus pyogenes infection by intranasal vaccination with a dual antigen component M protein/SfbI lipid core peptide vaccine formulation.
    Olive C; Schulze K; Sun HK; Ebensen T; Horváth A; Toth I; Guzman CA
    Vaccine; 2007 Feb; 25(10):1789-97. PubMed ID: 17229503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome-based intranasal delivery of lipopeptide vaccine candidates against group A streptococcus.
    Ghaffar KA; Marasini N; Giddam AK; Batzloff MR; Good MF; Skwarczynski M; Toth I
    Acta Biomater; 2016 Sep; 41():161-8. PubMed ID: 27063491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope.
    Olive C; Clair T; Yarwood P; Good MF
    Vaccine; 2002 Jun; 20(21-22):2816-25. PubMed ID: 12034109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide construct.
    Olive C; Batzloff M; Horváth A; Clair T; Yarwood P; Toth I; Good MF
    Indian J Med Res; 2004 May; 119 Suppl():88-94. PubMed ID: 15232170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197.
    Caro-Aguilar I; Ottinger E; Hepler RW; Nahas DD; Wu C; Good MF; Batzloff M; Joyce JG; Heinrichs JH; Skinner JM
    Hum Vaccin Immunother; 2013 Mar; 9(3):488-96. PubMed ID: 23249976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(hydrophobic amino acid) Conjugates for the Delivery of Multiepitope Vaccine against Group A Streptococcus.
    Azuar A; Shibu MA; Adilbish N; Marasini N; Hung H; Yang J; Luo Y; Khalil ZG; Capon RJ; Hussein WM; Toth I; Skwarczynski M
    Bioconjug Chem; 2021 Nov; 32(11):2307-2317. PubMed ID: 34379392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(hydrophobic Amino Acids) and Liposomes for Delivery of Vaccine against Group A Streptococcus.
    Azuar A; Madge HYR; Boer JC; Gonzalez Cruz JL; Wang J; Khalil ZG; Deceneux C; Goodchild G; Yang J; Koirala P; Hussein WM; Capon RJ; Plebanski M; Toth I; Skwarczynski M
    Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 36016100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bivalent mucosal peptide vaccines administered using the LCP carrier system stimulate protective immune responses against Streptococcus pyogenes infection.
    Schulze K; Ebensen T; Chandrudu S; Skwarczynski M; Toth I; Olive C; Guzman CA
    Nanomedicine; 2017 Nov; 13(8):2463-2474. PubMed ID: 28887213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.